CYP24A1 and myeloid sarcoma: Previously, we showed no difference in VDR and CYP24A1 expression between CD4+ T cells of MS and control donors (24), and others showed no differences between MS and control donors in suppression of CD4+ T cell proliferation and cytokine production by 1,25(OH)2D (25).